Advertisement

Hypoglycemia After Gastric Bypass: The Dark Side of GLP-1

Published:January 27, 2014DOI:https://doi.org/10.1053/j.gastro.2014.01.038
      See “Blockade of glucagon-like peptide 1 receptor corrects postprandial hypoglycemia after gastric bypass,” by Salehi M, Gastaldelli A, D'Alessio DA, on page 669.
      To read this article in full you will need to make a payment
      AGA Member Login
      Login with your AGA username and password.
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Sjostrom L.
        Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery.
        J Intern Med. 2013; 273: 219-234
        • Schauer P.R.
        • Kashyap S.R.
        • Wolski K.
        • et al.
        Bariatric surgery versus intensive medical therapy in obese patients with diabetes.
        N Engl J Med. 2012; 366: 1567-1576
        • Mingrone G.
        • Panunzi S.
        • De Gaetano A.
        • et al.
        Bariatric surgery versus conventional medical therapy for type 2 diabetes.
        N Engl J Med. 2012; 366: 1577-1585
        • Adams T.D.
        • Gress R.E.
        • Smith S.C.
        • et al.
        Long-term mortality after gastric bypass surgery.
        N Engl J Med. 2007; 357: 753-761
        • Service G.J.
        • Thompson G.B.
        • Service F.J.
        • et al.
        Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery.
        N Engl J Med. 2005; 353: 249-254
        • Patti M.E.
        • McMahon G.
        • Mun E.C.
        • et al.
        Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia.
        Diabetologia. 2005; 48: 2236-2240
        • Salehi M.
        • Gastaldelli A.
        • D'Alessio D.A.
        Blockade of glucagon-like peptide 1 receptor corrects postprandial hypoglycemia after gastric bypass.
        Gastroenterology. 2014; 146: 669-680
        • Marsk R.
        • Jonas E.
        • Rasmussen F.
        • et al.
        Nationwide cohort study of post-gastric bypass hypoglycaemia including 5,040 patients undergoing surgery for obesity in 1986-2006 in Sweden.
        Diabetologia. 2010; 53: 2307-2311
        • Zagury L.
        • Moreira R.O.
        • Guedes E.P.
        • et al.
        Insulinoma misdiagnosed as dumping syndrome after bariatric surgery.
        Obes Surg. 2004; 14: 120-123
        • Kellogg T.A.
        • Bantle J.P.
        • Leslie D.B.
        • et al.
        Postgastric bypass hyperinsulinemic hypoglycemia syndrome: characterization and response to a modified diet.
        Surg Obes Relat Dis. 2008; 4: 492-499
        • Valderas J.P.
        • Ahuad J.
        • Rubio L.
        • et al.
        Acarbose improves hypoglycaemia following gastric bypass surgery without increasing glucagon-like peptide 1 levels.
        Obes Surg. 2012; 22: 582-586
        • Halperin F.
        • Patti M.E.
        • Skow M.
        • et al.
        Continuous glucose monitoring for evaluation of glycemic excursions after gastric bypass.
        J Obes. 2011; 2011: 869536
        • Myint K.S.
        • Greenfield J.R.
        • Farooqi I.S.
        • et al.
        Prolonged successful therapy for hyperinsulinaemic hypoglycaemia after gastric bypass: the pathophysiological role of GLP1 and its response to a somatostatin analogue.
        Eur J Endocrinol. 2012; 166: 951-955
        • Spanakis E.
        • Gragnoli C.
        Successful medical management of status post-Roux-en-Y-gastric-bypass hyperinsulinemic hypoglycemia.
        Obes Surg. 2009; 19: 1333-1334
        • Moreira R.O.
        • Moreira R.B.
        • Machado N.A.
        • et al.
        Post-prandial hypoglycemia after bariatric surgery: pharmacological treatment with verapamil and acarbose.
        Obes Surg. 2008; 18: 1618-1621
        • Fernandez-Esparrach G.
        • Lautz D.B.
        • Thompson C.C.
        Peroral endoscopic anastomotic reduction improves intractable dumping syndrome in Roux-en-Y gastric bypass patients.
        Surg Obes Relat Dis. 2010; 6: 36-40
        • McLaughlin T.
        • Peck M.
        • Holst J.
        • et al.
        Reversible hyperinsulinemic hypoglycemia after gastric bypass: a consequence of altered nutrient delivery.
        J Clin Endocrinol Metab. 2010; 95: 1851-1855
        • Lee C.J.
        • Brown T.
        • Magnuson T.H.
        • et al.
        Hormonal response to a mixed-meal challenge after reversal of gastric bypass for hypoglycemia.
        J Clin Endocrinol Metab. 2013; 98: E1208-E1212
        • Meier J.J.
        • Butler A.E.
        • Galasso R.
        • et al.
        Hyperinsulinemic hypoglycemia after gastric bypass surgery is not accompanied by islet hyperplasia or increased {beta}-cell turnover.
        Diabetes Care. 2006; 29: 1554-1559
        • Goldfine A.B.
        • Mun E.C.
        • Devine E.
        • et al.
        Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal.
        J Clin Endocrinol Metab. 2007; 92: 4678-4685
        • Salehi M.
        • Prigeon R.L.
        • D'Alessio D.A.
        Gastric bypass surgery enhances glucagon-like Peptide 1-stimulated postprandial insulin secretion in humans.
        Diabetes. 2011; 60: 2308-2314
        • Jorgensen N.B.
        • Dirksen C.
        • Bojsen-Moller K.N.
        • et al.
        Exaggerated glucagon-like peptide 1 response is important for improved beta-cell function and glucose tolerance after Roux-en-Y gastric bypass in patients with type 2 diabetes.
        Diabetes. 2013; 62: 3044-3052
        • Reubi J.C.
        • Perren A.
        • Rehmann R.
        • et al.
        Glucagon-like peptide-1 (GLP-1) receptors are not overexpressed in pancreatic islets from patients with severe hyperinsulinaemic hypoglycaemia following gastric bypass.
        Diabetologia. 2010; 53: 2641-2645
        • Laferrere B.
        • Reilly D.
        • Arias S.
        • et al.
        Differential metabolic impact of gastric bypass surgery versus dietary intervention in obese diabetic subjects despite identical weight loss.
        Sci Transl Med. 2011; 3: 80re2
        • Liou A.P.
        • Paziuk M.
        • Luevano Jr., J.M.
        • et al.
        Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity.
        Sci Transl Med. 2013; 5: 178ra41
        • Patti M.E.
        • Houten S.M.
        • Bianco A.C.
        • et al.
        Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism.
        Obesity (Silver Spring). 2009; 17: 1671-1677
        • Hansen C.F.
        • Bueter M.
        • Theis N.
        • et al.
        Hypertrophy dependent doubling of L-cells in Roux-en-Y gastric bypass operated rats.
        PLoS ONE. 2013; 8: e65696
        • Mussig K.
        • Staiger H.
        • Machicao F.
        • et al.
        Genetic variants affecting incretin sensitivity and incretin secretion.
        Diabetologia. 2010; 53: 2289-2297

      Linked Article